ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • Register
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstract Number: 1863

Improving Pneumococcal Vaccination Rates in High Risk Rheumatology Patients

Heena Sheth1, Grimes Vera 2, Diana Rudge 2, Gary Fischer 2, Larry W. Moreland 1 and Rohit Aggarwal 3, 1University of Pittsburgh, Pittsburgh, PA, 2UPMC, Pittsburgh, 3University of Pittsburgh Medical Center, Pittsburgh, PA

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: Electronic Health Record, practice guidelines and immunosuppressants, quality improvement, Vaccines

  • Tweet
  • Email
  • Print
Save to PDF
Session Information

Date: Monday, November 11, 2019

Session Title: 4M112: Measures of Healthcare Quality I: Digital Health Technologies – Tool for Improvement (1860–1865)

Session Type: ACR Abstract Session

Session Time: 4:30PM-6:00PM

Background/Purpose: To improve Pneumococcal Vaccination rates in high risk Rheumatology patients on immunosuppressive therapy.

Methods: The study was a quality improvement project based on the pre-post-intervention design. The phase I of the project targeted all Rheumatoid Arthritis patients on immunosuppressive therapy for pneumovax vaccine (PV) seen in thirteen Rheumatology outpatient clinics (1/2013 to 7/2015). In the Phase II study (1/2015-10/2017) all Rheumatology patients on immunosuppressive medications irrespective of their diagnosis were intervened for pneumovax and prevnar vaccination as per current CDC guidelines. The electronic Best Practice Alert (BPA) for both PVs were developed with backend algorithm based on CDC guidelines. Based on patient eligibility checked electronically, the appropriate PV appeared on electronic medical records at the time of rooming of the eligible patient by the medical assistant. BPA was designed to inform the physician about vaccination status as well as enable physician to easily order PV or document refusal or deferral reasons (Figure 1). Education regarding vaccine guidelines, BPA, vaccination process, and regular feedback of results were important components of the project interventions. The vaccination rates during pre-post intervention phases during each study phase were compared using Chi square test.

Results: The PV rates reported as patients vaccinated among all eligible patients, improved significantly during both study phases. Phase I demonstrated 61.5% Pneumovax vaccination rate compared to pre-intervention rate of 27.9 % (p< 0.0001) (Figure 2). During Phase II 77% patients had received either pneumovax or prevnar compared to 49.6% patients in pre-intervention period (p< 0.0001) (Figure 3). The documentation rates (vaccine received, ordered, patient refusal and deferral reasons) also increased significantly in both phases. `

Conclusion: Electronic identification of vaccine eligibility and implementation of BPA with capabilities to order and document reasons for non-compliance significantly improved PV rates. The process required minimal modification of clinic work flow, and did not increase physician time. The project was self- sustained during Phase II with initial education and thus has potential for self-sustainability and generalizability.

Pneumococcal Vaccine Best Practice Alert

Figure 2: Pneumococcal Vaccination Improvement Rate Phase I

Figure 3: Pneumococcal Vaccine Improvement Rate Phase II


Disclosure: H. Sheth, None; G. Vera, None; D. Rudge, None; G. Fischer, None; L. Moreland, None; R. Aggarwal, Bristol Myers-Squibb, 2, 5, Pfizer, 2, Genentech, 2, Momenta, 2, Mallinckrodt, 2, 5, Octapharma, 5, CSL Behring, 5, AstraZeneca, 5, Corbus, 5, Kezar, 5.

To cite this abstract in AMA style:

Sheth H, Vera G, Rudge D, Fischer G, Moreland L, Aggarwal R. Improving Pneumococcal Vaccination Rates in High Risk Rheumatology Patients [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/improving-pneumococcal-vaccination-rates-in-high-risk-rheumatology-patients/. Accessed January 17, 2021.
  • Tweet
  • Email
  • Print
Save to PDF

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/improving-pneumococcal-vaccination-rates-in-high-risk-rheumatology-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Convergence: Where Rheumatology Meets. All Virtual. November 5-9.

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2021 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.